Objective: To investigate the effectiveness and complication rate of intravaginal gemeprost, a prostaglandin E, analogue, for second-trimester pregnancy termination in women with a scarred uterus. Methods: Of 439 women undergoing induced abortion between the 13th and the 23rd week of pregnancy, 67 had a scarred uterus because of 1 or more cesarean sections or myornectomy. All women received a 1 mg dose of gemeprost intravaginally every 3 h, up to 5 times over 24 h. Those who did not respond received further cycles of gemeprost treatment. Results: The rate of successful abortions among women with uterine scars was not different from that observed in the nultiparous controls, but previously vaginal delivery was associated with a shorter induction to abortion interval. The rate of severe complications did not differ between the groups, and was about 1%. Conclusion: The rate of complications following intravaginal administration of a PGE, analogue for second - trimester pregnancy termination was similar in women with a scarred or unscarred uterus. (c) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Intravaginal gemeprost and second-trimester pregnancy termination in the scarred uterus / Marinoni, Emanuela; Santoro, Maria; M. P., Vitagliano; A., Patella; Cosmi, Ermelando; DI IORIO, Romolo. - In: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. - ISSN 0020-7292. - STAMPA. - 97:1(2007), pp. 35-39. [10.1016/j.ijgo.2006.12.013]

Intravaginal gemeprost and second-trimester pregnancy termination in the scarred uterus

MARINONI, EMANUELA;SANTORO, Maria;COSMI, Ermelando;DI IORIO, Romolo
2007

Abstract

Objective: To investigate the effectiveness and complication rate of intravaginal gemeprost, a prostaglandin E, analogue, for second-trimester pregnancy termination in women with a scarred uterus. Methods: Of 439 women undergoing induced abortion between the 13th and the 23rd week of pregnancy, 67 had a scarred uterus because of 1 or more cesarean sections or myornectomy. All women received a 1 mg dose of gemeprost intravaginally every 3 h, up to 5 times over 24 h. Those who did not respond received further cycles of gemeprost treatment. Results: The rate of successful abortions among women with uterine scars was not different from that observed in the nultiparous controls, but previously vaginal delivery was associated with a shorter induction to abortion interval. The rate of severe complications did not differ between the groups, and was about 1%. Conclusion: The rate of complications following intravaginal administration of a PGE, analogue for second - trimester pregnancy termination was similar in women with a scarred or unscarred uterus. (c) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
2007
abortion; cesarean section; gemeprost; prostaglandin analogue; uterine scar
01 Pubblicazione su rivista::01a Articolo in rivista
Intravaginal gemeprost and second-trimester pregnancy termination in the scarred uterus / Marinoni, Emanuela; Santoro, Maria; M. P., Vitagliano; A., Patella; Cosmi, Ermelando; DI IORIO, Romolo. - In: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. - ISSN 0020-7292. - STAMPA. - 97:1(2007), pp. 35-39. [10.1016/j.ijgo.2006.12.013]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/103864
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact